Laura Téblick
YOU?
Author Swipe
View article: Unveiling Chlamydia trachomatis immunity in urogenital secretions: A systematic review
Unveiling Chlamydia trachomatis immunity in urogenital secretions: A systematic review Open
View article: Accelerating HPV-related cancer elimination – a meeting report
Accelerating HPV-related cancer elimination – a meeting report Open
The human papillomavirus (HPV) Prevention and Control Board organized a meeting to explore effective strategies for accelerating the elimination of HPV-related cancers, starting from WHO’s cervical cancer elimination campaign targets—vacci…
View article: First-void urine and cervicovaginal brushes as sampling devices for vaginal microbiome studies: a proof-of-concept study
First-void urine and cervicovaginal brushes as sampling devices for vaginal microbiome studies: a proof-of-concept study Open
This proof-of-concept study compares first-void urine (FVU) and cervicovaginal brushes to vaginal swabs for microbiome profiling in ten women. FVU and brushes provided comparable results in most cases, though storage conditions influenced …
View article: Home-based urinary HPV self-sampling for the detection of cervical cancer precursor lesions: attitudes and preferences from Belgian females participating in the CASUS study
Home-based urinary HPV self-sampling for the detection of cervical cancer precursor lesions: attitudes and preferences from Belgian females participating in the CASUS study Open
View article: Time-resolved fluorescence (TRF) for total IgG and HPV16-specific antibody detection in first-void urine and serum: A comparative study
Time-resolved fluorescence (TRF) for total IgG and HPV16-specific antibody detection in first-void urine and serum: A comparative study Open
Recent studies demonstrated that human papillomavirus (HPV) specific immunoglobulins (IgG) are present and detectable in non-invasively collected first-void urine (FVU) samples. As IgG levels in urine are low, we evaluated the potential of…
View article: Stability, enrichment, and quantification of total and HPV16-specific IgG present in first-void urine
Stability, enrichment, and quantification of total and HPV16-specific IgG present in first-void urine Open
First-void urine (FVU) samples, containing human papillomavirus (HPV)-specific IgG from female genital tract secretions, provide a non-invasive option for disease monitoring and vaccine impact assessment. This study explores the utility of…
View article: Home-based urinary HPV self-sampling for the detection of cervical cancer precursor lesions: attitudes and preferences from Belgian females participating in the CASUS study
Home-based urinary HPV self-sampling for the detection of cervical cancer precursor lesions: attitudes and preferences from Belgian females participating in the CASUS study Open
Background Cervical cancer (CC) is the fourth most common cancer globally in females, caused by oncogenic infections with high-risk human papillomavirus (hrHPV) strains. Successful CC screening programs strongly depend on the participation…
View article: HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity
HPV-specific antibodies in female genital tract secretions captured via first-void urine retain their neutralizing capacity Open
Human papillomavirus (HPV) vaccines, primarily relying on neutralizing antibodies, have proven highly effective. Recently, HPV-specific antibodies have been detected in the female genital tract secretions captured by first-void urine (FVU)…
View article: Concentration strategies for spiked and naturally present biomarkers in non-invasively collected first-void urine
Concentration strategies for spiked and naturally present biomarkers in non-invasively collected first-void urine Open
View article: Follow‐up of humoral immune response after HPV vaccination using first‐void urine: A longitudinal cohort study
Follow‐up of humoral immune response after HPV vaccination using first‐void urine: A longitudinal cohort study Open
Assessment of humoral immune responses following human papillomavirus (HPV) vaccination currently relies on invasive blood sampling. This longitudinal cohort study explores the usability of first‐void urine as a noninvasive alternative sam…
View article: Cover Image, Volume 95, Number 10, October 2023
Cover Image, Volume 95, Number 10, October 2023 Open
Front Cover Caption: The cover image is based on the Research Article Follow-up of humoral immune response after HPV vaccination using first-void urine: A longitudinal cohort study by Laura Téblick et al., https://doi.org/10.1002/jmv.29133.
View article: An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report
An update on one-dose HPV vaccine studies, immunobridging and humoral immune responses – A meeting report Open
View article: Follow-Up of HPV Vaccination Using First-Void Urine as a Genital Tract Liquid Biopsy: A Longitudinal Cohort Study
Follow-Up of HPV Vaccination Using First-Void Urine as a Genital Tract Liquid Biopsy: A Longitudinal Cohort Study Open
View article: Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine
Impact of Collection Volume and DNA Extraction Method on the Detection of Biomarkers and HPV DNA in First-Void Urine Open
The potential of first-void (FV) urine as a non-invasive liquid biopsy for detection of human papillomavirus (HPV) DNA and other biomarkers has been increasingly recognized over the past decade. In this study, we investigated whether the v…
View article: Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine
Non-invasive Assessment of Vaccine-Induced HPV Antibodies via First-Void Urine Open
The potential of first-void (FV) urine as a non-invasive method to monitor human papillomavirus (HPV) vaccination has been reported, mainly focusing on urine as a sample to assess HPV DNA. Besides HPV DNA, vaccine-induced HPV antibodies or…
View article: Comparison of a VLP‐based and GST‐L1‐based multiplex immunoassay to detect vaccine‐induced HPV‐specific antibodies in first‐void urine
Comparison of a VLP‐based and GST‐L1‐based multiplex immunoassay to detect vaccine‐induced HPV‐specific antibodies in first‐void urine Open
Vaccine‐induced human papillomavirus (HPV) antibodies originating from cervicovaginal secretions were recently shown to be detectable in first‐void (FV) urine. This presents a novel opportunity for noninvasive sampling to monitor HPV antib…
View article: HPV DNA detection in urine samples of women: ‘an efficacious and accurate alternative to cervical samples?’
HPV DNA detection in urine samples of women: ‘an efficacious and accurate alternative to cervical samples?’ Open
Cervical cancers are caused by persistent human papillomavirus (HPV) infections [1]. To date, HPV DNA testing using clinician-obtained cervical cells is the reference for identifying cervical infec...